Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SAfiledCriticalRoussel Uclaf SA
Priority to FR904208ApriorityCriticalpatent/FR2458M/fr
Application grantedgrantedCritical
Publication of FR2458MpublicationCriticalpatent/FR2458M/fr
C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
C07D209/04—Indoles; Hydrogenated indoles
C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
C07D209/16—Tryptamines
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
FR904208A1962-07-171962-07-17Nouveau médicament notamment pour le traitement des états dépressifs ou d'anxiété.
ActiveFR2458M
(fr)